Taste Supra-thresholds Among a Sample of Depressed Egyptian Adult Under Anti-depressants Therapy
NCT04923321 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2022-02-17
Summary
Determine the taste intensity at supra-threshold among a sample of depressed Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3 months) using filter paper disc(FPD) method using a psychophysical method through a scoring system.
Conditions
- Taste Disorders
Sponsors & Collaborators
-
Cairo University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-22
- Primary Completion
- 2021-04-08
- Completion
- 2021-05-07
Countries
- Egypt
Study Locations
More Related Trials
-
LSD Therapy for Persons Suffering From Major Depression
NCT03866252 ·Status: COMPLETED ·Phase: PHASE2
-
Mood Effects of Serotonin Agonists
NCT03790358 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
NCT04984512 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT04916548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Antidepressants on Back Pain
NCT00018200 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of HS-10353 in Adult Participants With Major Depressive Disorder
NCT05938179 ·Status: UNKNOWN ·Phase: PHASE2
-
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
NCT04101474 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.
NCT00775203 ·Status: COMPLETED ·Phase: PHASE3
-
the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT04623814 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder
NCT01919008 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects
NCT04591301 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
NCT00913822 ·Status: COMPLETED ·Phase: PHASE1
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT05991232 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
NCT05320107 ·Status: RECRUITING ·Phase: PHASE1
-
Naturalistic Study of Ketamine in the Treatment of Depression
NCT05249309 ·Status: UNKNOWN
-
Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
NCT00759395 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05973851 ·Status: RECRUITING ·Phase: PHASE3
-
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
NCT04234776 ·Status: UNKNOWN ·Phase: PHASE4
-
Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression
NCT00386841 ·Status: COMPLETED ·Phase: PHASE4
-
A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
NCT04226963 ·Status: COMPLETED
-
ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression
NCT06408246 ·Status: RECRUITING ·Phase: PHASE2
-
Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
NCT02992496 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05550532 ·Status: COMPLETED ·Phase: PHASE3
-
Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
NCT00384436 ·Status: COMPLETED ·Phase: PHASE4
-
Acupuncture and Escitalopram for Treating Major Depression Clinical Study
NCT05901571 ·Status: NOT_YET_RECRUITING ·Phase: NA